Stay updated on Atezolizumab in Esophageal Cancer: Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab in Esophageal Cancer: Clinical Trial page.

Latest updates to the Atezolizumab in Esophageal Cancer: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now shows a 403 Forbidden error with a basic header and a Home link. This replaces the previous display of the trial's details, locations, and study information.SummaryDifference17%

- Check17 days agoChange DetectedThe locations count is updated to 166 with Siriraj Hospital (Bangkok, Thailand) removed from the list of sites. The study status has changed from Active, not recruiting to Completed.SummaryDifference0.3%

- Check31 days agoChange DetectedA new page revision tag has been added (Revision: v3.6.6). The previous revision tag (Revision: v3.6.5) has been removed.SummaryDifference0.0%

- Check38 days agoChange DetectedA Publications section has been added to the study page, including a PubMed citation for the related research and a note that publications are auto-filled from PubMed.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page's revision label updated from v3.6.4 to v3.6.5, indicating a new version for maintenance or minor improvements.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page shows updated last update dates in July 2026, indicating an administrative refresh of the study listing rather than changes to the trial design, eligibility criteria, or outcomes.SummaryDifference0.1%

Stay in the know with updates to Atezolizumab in Esophageal Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab in Esophageal Cancer: Clinical Trial page.